Anti-Human RIOX1/C14ORF169 IP Antibody (SAA0194)

Description: Anti-Human RIOX1/C14ORF169 IP Antibody (SAA0194) [SAA0194] (RA14589) is a mouse monoclonal antibody detecting C14orf169 in ELISA, IF, IP. Suitable for Human.
Highlights:
• Multi-Application — Validated across multiple applications.
Host species: Mouse
Isotype: IgG2a
Species reactivity: Human
Form: Liquid
Storage buffer: 0.01M PBS, pH 7.4.
Concentration: 1 mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: ELISA, IF, IP
Target: ROX, MAPJD, C14orf169, hsNO66, Myc-associated protein with JmjC domain, Ribosomal oxygenase 1, Nucleolar protein 66, Ribosomal oxygenase NO66, Histone lysine demethylase NO66, 60S ribosomal protein L8 histidine hydroxylase, NO66, Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66, RIOX1
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: Please contact with the lab for this information.
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names:
Background: Ribosomal oxygenase 1 (RIOX1/C14ORF169) is a ~71 kDa protein. Oxygenase that can act as both a histone lysine demethylase and a ribosomal histidine hydroxylase. Specifically demethylates 'Lys-4' (H3K4me) and 'Lys-36' (H3K36me) of histone H3, thereby playing a central role in histone code. Preferentially demethylates trimethylated H3 'Lys-4' (H3K4me3) and monomethylated H3 'Lys-4' (H3K4me1) residues, while it has weaker activity for dimethylated H3 'Lys-36' (H3K36me2). Acts as a regulator of osteoblast differentiation via its interaction with SP7/OSX by demethylating H3K4me and H3K36me, thereby inhibiting SP7/OSX-mediated promoter activation. Also catalyzes demethylation of non-histone proteins, such as CGAS: demethylation of monomethylated CGAS promotes interaction between CGAS and PARP1, followed by PARP1 inactivation.
References:
1. Ge, W. et al. (2012) Nature chemical biology 8, 960-962. PMID: 23103944
2. Suzuki, C. et al. (2007) Molecular cancer therapeutics 6, 542-51. PMID: 17308053
Note: For research use only.